نتائج البحث - Eng‐Huat Tan

تنقيح النتائج
  1. 1
    Management of epidermal growth factor receptor tyrosine kinase inhibitor‐related cutaneous and gastrointestinal toxicities

    Management of epidermal growth factor receptor tyrosine kinase inhibitor‐related cutaneous and gastrointestinal toxicities حسب Derrick Chen‐Wee Aw, Eng Huat Tan, Tan Min Chin, Hong Liang Lim, Haur Yueh Lee, Ross A. Soo

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer

    Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer حسب Qingyu Zhou, Alex Sparreboom, Eng‐Huat Tan, Yin‐Bun Cheung, Ann Lee, Donald Poon, Edmund J.D. Lee, Balram Chowbay

    منشور في 2005
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinoma

    Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinoma حسب Swan‐Swan Leong, Joseph Wee, Miah Hiang Tay, Chee‐Keong Toh, Say Beng Tan, Choon Hua Thng, Kian Fong Foo, Wan‐Teck Lim, Terence Tan, Eng Huat Tan

    منشور في 2004
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Gefitinib (IRESSA) in Patients of Asian Origin with Refractory Advanced Non-small Cell Lung Cancer: Subset Analysis from the ISEL Study

    Gefitinib (IRESSA) in Patients of Asian Origin with Refractory Advanced Non-small Cell Lung Cancer: Subset Analysis from the ISEL Study حسب Alex Y. Chang, Purvish M. Parikh, Sumitra Thongprasert, Eng Huat Tan, Reury-Perng Perng, Domingo Ganzon, James Chih‐Hsin Yang, Chao‐Jung Tsao, Claire Watkins, N. Botwood, Nick Thatcher

    منشور في 2006
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Examining Treatment Outcomes with Erlotinib in Patients with Advanced Non–Small Cell Lung Cancer Whose Tumors Harbor Uncommon EGFR Mutations

    Examining Treatment Outcomes with Erlotinib in Patients with Advanced Non–Small Cell Lung Cancer Whose Tumors Harbor Uncommon EGFR Mutations حسب Barbara Klughammer, Wolfram Brugger, Federico Cappuzzo, Tudor‐Eliade Ciuleanu, Tony Mok, Martin Reck, Eng Huat Tan, Paul Delmar, Gaëlle Klingelschmitt, Anny-Yue Yin, Olivia Spleiss, Lin Wu, David S. Shames

    منشور في 2016
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    EGFR Mutation Subtypes Influence Survival Outcomes following First-Line Gefitinib Therapy in Advanced Asian NSCLC Patients

    EGFR Mutation Subtypes Influence Survival Outcomes following First-Line Gefitinib Therapy in Advanced Asian NSCLC Patients حسب Natalia Sutiman, Shao Weng Tan, Eng Huat Tan, Wan‐Teck Lim, Ravindran Kanesvaran, Quan Sing Ng, Amit Jain, Mei‐Kim Ang, Wan Ling Tan, Chee‐Keong Toh, Balram Chowbay

    منشور في 2016
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    A Randomized Phase 2 Study Comparing the Combination of Ficlatuzumab and Gefitinib with Gefitinib Alone in Asian Patients with Advanced Stage Pulmonary Adenocarcinoma

    A Randomized Phase 2 Study Comparing the Combination of Ficlatuzumab and Gefitinib with Gefitinib Alone in Asian Patients with Advanced Stage Pulmonary Adenocarcinoma حسب Tony Mok, Sarayut Lucien Geater, Wu‐Chou Su, Eng-Huat Tan, James Chih‐Hsin Yang, Gee‐Chen Chang, May Han, Philip Komarnitsky, Francis Payumo, Jennifer Garrus, Sandra Close, Keunchil Park

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Never-Smokers With Lung Cancer: Epidemiologic Evidence of a Distinct Disease Entity

    Never-Smokers With Lung Cancer: Epidemiologic Evidence of a Distinct Disease Entity حسب Chee‐Keong Toh, Fei Gao, Wan‐Teck Lim, Swan‐Swan Leong, Kam-Weng Fong, Swee‐Peng Yap, Anne Ann Ling Hsu, Philip Eng, Heng‐Nung Koong, Thirugnanam Agasthian, Eng-Huat Tan

    منشور في 2006
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Impact of afatinib dose modification on safety and effectiveness in patients with EGFR mutation-positive advanced NSCLC: Results from a global real-world study (RealGiDo)

    Impact of afatinib dose modification on safety and effectiveness in patients with EGFR mutation-positive advanced NSCLC: Results from a global real-world study (RealGiDo) حسب Balázs Halmos, Eng-Huat Tan, Ross A. Soo, Jacques Cadranel, Min Ki Lee, Pascal Foucher, Te‐Chun Hsia, Maximilian J. Hochmair, Frank Griesinger, Toyoaki Hida, Edward Kim, Barbara Melosky, Angela Märten, Enric Carcereny

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    A Phase II Study of Pazopanib in Asian Patients with Recurrent/Metastatic Nasopharyngeal Carcinoma

    A Phase II Study of Pazopanib in Asian Patients with Recurrent/Metastatic Nasopharyngeal Carcinoma حسب Wan‐Teck Lim, Quan‐Sing Ng, Percy Ivy, Swan-Swan Leong, Onkar Singh, Balram Chowbay, Fei Gao, Choon Hua Thng, Boon-Cher Goh, Daniel Shao-Weng Tan, Tong San Koh, Chee‐Keong Toh, Eng-Huat Tan

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10‐year update and subset analysis

    Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and ne... حسب N. Gopalakrishna Iyer, Daniel Shao-Weng Tan, Veronique KM Tan, Weining Wang, Jacqueline Siok Gek Hwang, Ngian‐Chye Tan, Ranjiv Sivanandan, Hiang Khoon Tan, Wan‐Teck Lim, Mei‐Kim Ang, Joseph Wee, Khee‐Chee Soo, Eng Huat Tan

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Genomic Profiles Specific to Patient Ethnicity in Lung Adenocarcinoma

    Genomic Profiles Specific to Patient Ethnicity in Lung Adenocarcinoma حسب Philippe Broët, Cyril Dalmasso, Eng Huat Tan, Marco Alifano, Shenli Zhang, Jeanie Wu, Ming Hui Lee, Jean‐François Régnard, Wan‐Teck Lim, Heng Nung Koong, Thirugnanam Agasthian, Lance D. Miller, Elaine Hsuen Lim, Sophie Camilleri‐Bröet, Patrick Tan

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Bosutinib inhibits migration and invasion via ack1 in kras mutant non-small cell lung cancer

    Bosutinib inhibits migration and invasion via ack1 in kras mutant non-small cell lung cancer حسب Daniel S.W. Tan, Benjamin Haaland, Jia Gan, Su Chin Tham, Indrajit Sinha, Eng Huat Tan, Kiat Hon Lim, Angela Takano, Sai Sakktee Krisna, Minn Minn Myint Thu, Hoe Peng Liew, Axel Ullrich, Wan‐Teck Lim, Boon Tin Chua

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Intertumor heterogeneity of non‐small‐cell lung carcinomas revealed by multiplexed mutation profiling and integrative genomics

    Intertumor heterogeneity of non‐small‐cell lung carcinomas revealed by multiplexed mutation profiling and integrative genomics حسب Daniel S.W. Tan, Sophie Camilleri‐Bröet, Eng Huat Tan, Marco Alifano, Wan‐Teck Lim, Antonio Bobbio, Shenli Zhang, Quan‐Sing Ng, Mei‐Kim Ang, N. Gopalakrishna Iyer, Angela Takano, Kiat Hon Lim, Jean‐François Régnard, Patrick Tan, Philippe Broët

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Intratumoral CD39+CD8+ T Cells Predict Response to Programmed Cell Death Protein-1 or Programmed Death Ligand-1 Blockade in Patients With NSCLC

    Intratumoral CD39+CD8+ T Cells Predict Response to Programmed Cell Death Protein-1 or Programmed Death Ligand-1 Blockade in Patients With NSCLC حسب Joe Yeong, Lisda Suteja, Yannick Simoni, Kah Weng Lau, Aaron C. Tan, Hui Hua Li, Sherlly Lim, Jie Hua Loh, Felicia Wee, Sanjna Nilesh Nerurkar, Angela Takano, Eng Huat Tan, Tony Kiat Hon Lim, Evan W. Newell, Daniel S.W. Tan

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Randomized Trial of Radiotherapy Versus Concurrent Chemoradiotherapy Followed by Adjuvant Chemotherapy in Patients With American Joint Committee on Cancer/International Union Against Cancer Stage III and IV Nasopharyngeal Cancer of the Endemic Variety

    Randomized Trial of Radiotherapy Versus Concurrent Chemoradiotherapy Followed by Adjuvant Chemotherapy in Patients With American Joint Committee on Cancer/International Union Again... حسب Joseph Wee, Eng Huat Tan, Bee Choo Tai, Hwee Bee Wong, Swan Swan Leong, Terence Tan, Eu Tiong Chua, Edward S. Yang, Khai Mun Lee, Kam Weng Fong, Hoon Seng Khoo Tan, Kim Shang Lee, Susan Loong, Vijay Sethi, E. Chua, David Machin

    منشور في 2005
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Erlotinib in Previously Treated Non–Small-Cell Lung Cancer

    Erlotinib in Previously Treated Non–Small-Cell Lung Cancer حسب Frances A. Shepherd, José Rodrigues Pereira, Tudor‐Eliade Ciuleanu, Eng Huat Tan, Vera Hirsh, Sumitra Thongprasert, Daniel de Castro, Savitree Maoleekoonpiroj, Michael Smylie, Renato Martins, Maximiliano Van Kooten, Mircea Dediu, B. Findlay, Dongsheng Tu, D. Johnston, Andrea Bezjak, Gary M. Clark, P. Santabárbara, Lesley Seymour

    منشور في 2005
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Impact of EGFR Inhibitor in Non–Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis

    Impact of EGFR Inhibitor in Non–Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis حسب Chee Khoon Lee, Chris Brown, Richard J. Gralla, Vera Hirsh, Sumitra Thongprasert, Chun‐Ming Tsai, Eng Huat Tan, Jcm Ho, D. Chu, Adel Zaatar, Jemela Anne Osorio Sanchez, Vu Van Vu, Joseph S. K. Au, Akira Inoue, Siow Ming Lee, Val Gebski, James Chih‐Hsin Yang

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Adoptive T-cell Transfer and Chemotherapy in the First-line Treatment of Metastatic and/or Locally Recurrent Nasopharyngeal Carcinoma

    Adoptive T-cell Transfer and Chemotherapy in the First-line Treatment of Metastatic and/or Locally Recurrent Nasopharyngeal Carcinoma حسب Whay-Kuang Chia, Marissa Teo, Who-Whong Wang, Bernett Lee, Soo-Fan Ang, Wai-Meng Tai, Chit-Lai Chee, Joanna Ng, Rebecca Kan, Wan‐Teck Lim, Sze Huey Tan, Whee-Sze Ong, Yin‐Bun Cheung, Eng-Huat Tan, John E. Connolly, Stephen Gottschalk, Gwo Fuang Ho

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Phase 2 Trial of Linifanib (ABT-869) in Patients with Advanced Non-small Cell Lung Cancer

    Phase 2 Trial of Linifanib (ABT-869) in Patients with Advanced Non-small Cell Lung Cancer حسب Eng-Huat Tan, Glenwood Goss, Ravi Salgia, Benjamin Besse, David R. Gandara, Nasser H. Hanna, James Chih‐Hsin Yang, Raymond Thertulien, M. S. Wertheim, Julien Mazières, Thomas Hensing, Christa Lee, Neeraj Gupta, Rajendra Pradhan, Jiang Qian, Qin Qin, Frank A. Scappaticci, Justin L. Ricker, Dawn M. Carlson, Ross A. Soo

    منشور في 2011
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: